Genelux Corporation (GNLX:NASDAQ) closed at $2.00 on October 23, 2026, up 1.01% on the day. The stock trades 76.6% below its 52-week high of $8.54 and 5.3% above its 52-week low of $1.90. Over the past year, it lost 74.4%. Genelux Corporation is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, GNLX closed higher on 112 days (44%). Its best day was October 23, 2025 (+22.19%) and its worst was November 6, 2025 (-32.40%). The stock moved 10% or more in a single session 8 times.
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.
Find more stocks like GNLX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.